Literature DB >> 1395473

Evidence for reversibility of defective counterregulation in a patient with insulinoma.

A Maran1, J Taylor, I A Macdonald, S A Amiel.   

Abstract

To investigate her unheralded neuroglycopenia, a 45-year-old woman was studied before and 3 months after removal of her insulinoma. Hypoglycaemia was induced and reversed by glucose infusion during 4-h insulin infusions (1.5 mU kg-1 min-1). Postoperatively, the low preoperative adrenaline, noradrenaline, growth hormone, and cortisol responses increased by 490, 152, 64, and 178%, respectively, and started at higher glucose levels (2.7 vs 1.9 mmol l-1 for adrenaline), with a four-fold increase in autonomic symptoms and more profound psychomotor dysfunction. We conclude that the syndrome of recurrent severe hypoglycaemia with defective warning symptoms and hormonal responses, in this case induced by an insulin-secreting tumour, is reversible, perhaps by the removal of the hypoglycaemia, a finding which may be relevant to other patients with recurrent severe hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1395473     DOI: 10.1111/j.1464-5491.1992.tb01889.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

1.  Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans.

Authors:  S N Davis; C Shavers; F Costa; R Mosqueda-Garcia
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  Metabolic neuroimaging of the brain in diabetes mellitus and hypoglycaemia.

Authors:  Yee-Seun Cheah; Stephanie A Amiel
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

3.  Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses.

Authors:  S N Davis; C Shavers; B Davis; F Costa
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

4.  Cognitive, neurophysiologic and metabolic sequelae of previous hypoglycemic coma revealed by hyperinsulinemic-hypoglycemic clamp in type 1 diabetic patients.

Authors:  Alberto Maran; Cristina Crepaldi; Franco Del Piccolo; Ian Macdonald; Lisa Zarantonello; Angelo Avogaro; Piero Amodio
Journal:  Metab Brain Dis       Date:  2017-06-06       Impact factor: 3.584

5.  Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.

Authors:  C Fanelli; S Pampanelli; L Epifano; A M Rambotti; A Di Vincenzo; F Modarelli; M Ciofetta; M Lepore; B Annibale; E Torlone
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

6.  Gender differences in counterregulation to hypoglycaemia.

Authors:  S A Amiel; A Maran; J K Powrie; A M Umpleby; I A Macdonald
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

7.  Hypoglycemia unawareness in a patient with dumping syndrome: report of a case.

Authors:  F Bellini; L Sammicheli; L Ianni; C Pupilli; M Serio; M Mannelli
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

8.  Reversible Adrenal Insufficiency in Three Patients With Post-Roux-en-Y Gastric Bypass Noninsulinoma Pancreatogenous Hypoglycemia Syndrome.

Authors:  Shelly Mathur; Jasmine Boparai; Sanjay N Mediwala; Jose M Garcia; Glenn R Cunningham; Marco Marcelli; Madhuri M Vasudevan
Journal:  J Investig Med High Impact Case Rep       Date:  2014-03-13

9.  Anaesthetic management of excision of a functioning pancreatic beta cell tumour.

Authors:  Pasupuleti Hemalatha; R Sri Devi; Aloka Samantaray; N Hemanth; Mangu Hanumantha Rao
Journal:  Indian J Anaesth       Date:  2014 Nov-Dec

10.  Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial.

Authors:  Lalantha Leelarathna; Stuart A Little; Emma Walkinshaw; Horng Kai Tan; Alexandra Lubina-Solomon; Kavita Kumareswaran; Annette P Lane; Thomas Chadwick; Sally M Marshall; Jane Speight; Daniel Flanagan; Simon R Heller; James A M Shaw; Mark L Evans
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.